ASMB · Assembly Biosciences Inc
United States · RS rating 11 · As of 2026-10-14
| Price | 20.53 USD |
|---|---|
| 1-day change | +0.9% |
| RS rating (overall / 1M / 3M / 12M) | 11 / 10 / 19 / 23 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 33 / 9 / 45 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +63.0% |
| Sales growth Q/Q | +293.6% |
| Distance from 52-week high | +46.7% |
| Market cap (USD) | $450.2M |